Restoris Multicompartmental Knee (MCK) System is an implant system designed to be used with MAKO'...
FDA Device Recall #Z-1132-2014 — Class II — January 9, 2014
Recall Summary
| Recall Number | Z-1132-2014 |
| Classification | Class II — Moderate risk |
| Date Initiated | January 9, 2014 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Mako Surgical Corporation |
| Location | Plantation, FL |
| Product Type | Devices |
| Quantity | 41 units |
Product Description
Restoris Multicompartmental Knee (MCK) System is an implant system designed to be used with MAKO's Robotic Arm Interactive Orthopedic System (RIO). It is composed of a unicompartmental implant system (Restoris MCK Uni) and a patellofemoral implant system (Restoris MCK PF). The Restoris MCK Uni is designed for use when load bearing ROM is expected to be less than or equal to 155 degrees. In Restoris MCK combination where multi-compartmental areas are being treated, the Restoris MCK components were designed with 3 mm of gap between the components to ensure that the components do not interfere. Is indicated for single or multi-compartmental knee replacement used in conjunction with RIO, in individuals with osteoarthritis or post-traumatic arthritis of the tibiofemoral and/or patellofemoral articular surfaces.
Reason for Recall
The product may be mislabeled and could result in the incorrect implant being used.
Distribution Pattern
Nationwide distribution including AZ, FL, HI, OH, MI, NC NH, WA, TX, WI, OK, CA, RI, LA, ID, IL, IN, and TN.
Lot / Code Information
Part Number #180704-1, Lot #12151013-1.
Other Recalls from Mako Surgical Corporation
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1735-2022 | Class II | Stryker USB Converter, Polaris Spectra Camera, ... | Aug 8, 2022 |
| Z-0472-2021 | Class II | Mako Integrated Cutting System (MICS) Handpiece... | Oct 23, 2020 |
| Z-2745-2020 | Class II | Mako Hip End Effector, Variable Angle Catalog ... | Jul 9, 2020 |
| Z-1824-2019 | Class II | 2.7 Degree Straight Sagittal Saw attachment (Ma... | Apr 25, 2019 |
| Z-1823-2019 | Class II | 2.7 Degree Angled Sagittal Saw attachment (Mako... | Apr 25, 2019 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.